Article metrics

Download PDFPDF

CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019030
Jan 2020030
Feb 2020010
May 2020030
Jun 20200110
Jul 2020020
Aug 2020010
Sep 2020050
Oct 2020030
Nov 2020050
Dec 2020010
Jan 2021020
Feb 2021001
Mar 2021030
Apr 2021031
May 2021021
Jun 2021020
Jul 2021030
Aug 2021010
Sep 2021040
Oct 2021081
Nov 2021042
Dec 2021060
Jan 2022050
Feb 2022020
Mar 2022010
Apr 2022031
May 2022040
Jun 2022001
Jul 2022061
Aug 2022031
Sep 2022070
Oct 2022011
Nov 2022070
Dec 2022050
Jan 2023020
Feb 2023010
Mar 2023020
May 2023010
Jun 2023030
Jul 2023011
Aug 2023010
Sep 2023030
Oct 2023011
Nov 2023051
Dec 20230100
Jan 2024010
Feb 2024060
Mar 2024040
Total016114